Inventor
MARTINELLI MICHAEL JOHN
US26 patents
⚠️ This page may combine multiple inventors who share the name “MARTINELLI MICHAEL JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
12 patentsUS5731324AMar 24, 1998
Glycoprotein IIb/IIIa antagonists
LILLY CO ELI37 citations91
US6448269B1Sep 10, 2002
Glycoprotein IIb/IIIa antagonists
LILLY CO ELI7 citations72
US6020362AFeb 1, 2000
Glycoprotein IIB IIIA antagonists
LILLY CO ELI6 citations72
US7186715B2Mar 6, 2007
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
LILLY CO ELI6 citations71
US7169777B2Jan 30, 2007
Melanocortin receptor agonists
LILLY CO ELI8 citations71
US6713505B2Mar 30, 2004
spla2 inhibitors
LILLY CO ELI2 citations62
US7314879B2Jan 1, 2008
Melanocortin receptor agonists
LILLY CO ELI5 citations60
US7157463B2Jan 2, 2007
Substituted piperidines/piperazines as melanocortin receptor agonists
LILLY CO ELI3 citations60
US7291619B2Nov 6, 2007
Melanocortin receptor agonists
LILLY CO ELI2 citations59
US6579886B2Jun 17, 2003
Selective iglur5 receptor antagonists
LILLY CO ELI4 citations58
US6384041B1May 7, 2002
Bicyclic sPLA2 inhibitors
LILLY CO ELI5 citations56
US5986106ANov 16, 1999
Process for preparing 4-substituted-1H-indole-3-glyoxamides
LILLY CO ELI2 citations50
FIBROGEN INC
7 patentsUS8883823B2Nov 11, 2014
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC20 citations92
US9617218B2Apr 11, 2017
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC5 citations84
US9371288B2Jun 21, 2016
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC7 citations84
US9115085B2Aug 25, 2015
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC12 citations84
US10272078B2Apr 30, 2019
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC2 citations73
US10118897B2Nov 6, 2018
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC2 citations73
US9918977B2Mar 20, 2018
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC3 citations73
ARENA PHARM INC
4 patentsUS9447041B2Sep 20, 2016
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC12 citations91
US9175320B2Nov 3, 2015
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC15 citations91
US11149292B2Oct 19, 2021
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC8 citations83
US11674163B2Jun 13, 2023
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC0 citations61